Apex Biotechnology Corp
TWSE:1733
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apex Biotechnology Corp
TWSE:1733
|
TW |
|
F
|
F4 Uranium Corp
XTSX:FFU
|
CA |
|
Ampacs Corp
TWSE:6743
|
TW |
|
First Resources Ltd
SGX:EB5
|
SG |
|
Adalta Ltd
ASX:1AD
|
AU |
|
Hotel Newgrand Co Ltd
TSE:9720
|
JP |
|
K
|
Kirby Corp
F:KIY
|
US |
|
Ballard Power Systems Inc
TSX:BLDP
|
CA |
|
T
|
Tractor Supply Co
F:TR4
|
US |
|
O
|
Osaka Gas Co Ltd
F:OSA
|
JP |
|
M
|
MTU Aero Engines AG
DUS:MTX
|
DE |
|
Tenet Healthcare Corp
NYSE:THC
|
US |
|
Groupe Pizzorno Environnement SA
PAR:GPE
|
FR |
|
Greif Inc
F:GB6B
|
US |
|
K
|
KLA Corp
F:KLA
|
US |
|
Loomis AB
F:K900
|
SE |
|
E
|
Expand Energy Corp
F:CS1
|
US |
|
Energy Resources Of Australia Ltd
ASX:ERA
|
AU |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
Alteogen Inc
KOSDAQ:196170
|
KR |
Dividends
Dividend Yield
Apex Biotechnology Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Apex Biotechnology Corp
Apex Biotechnology Corp have decreased by 0%.
Payout Ratio
Apex Biotechnology Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Apex Biotechnology Corp is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Apex Biotechnology Corp
| Average Annual Return | 7.23% |
| Standard Deviation of Annual Returns | 30.51% |
| Max Drawdown | -38% |
| Market Capitalization | 3B TWD |
| Shares Outstanding | 99 950 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Apex Biotechnology Corp's latest stock split occurred on Aug 31, 2012
The company executed a 964-for-961 stock split, meaning that for every 961 shares held, investors received 964 new shares.
Before the split, Apex Biotechnology Corp traded at 75.836 per share. Afterward, the share price was about 50.101.
The adjusted shares began trading on Aug 31, 2012. This was stock split number 8 in Apex Biotechnology Corp's history, following the previous one in Jul 1, 2009.